Fig. 6From: Cell-based cytotoxicity assays for engineered nanomaterials safety screening: exposure of adipose derived stromal cells to titanium dioxide nanoparticlesLipid accumulation in ADSCs differentiated for 3 weeks in the presence of 0.1 mg/mL (a) and 0.4 mg/mL (b) anatase and rutile TiO2 NPsBack to article page